E Eriksson

775 total citations
16 papers, 651 citations indexed

About

E Eriksson is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, E Eriksson has authored 16 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in E Eriksson's work include Immune Cell Function and Interaction (10 papers), Glycosylation and Glycoproteins Research (3 papers) and Immunotherapy and Immune Responses (3 papers). E Eriksson is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Glycosylation and Glycoproteins Research (3 papers) and Immunotherapy and Immune Responses (3 papers). E Eriksson collaborates with scholars based in United States, Sweden and Germany. E Eriksson's co-authors include Rolf Kiessling, William E. Seaman, Klas Kärre, Marvin H. Sleisenger, G C Koo, John B. Imboden, Alvar Grönberg, Raymond M. Welsh, R C Burton and Svante Hermodsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

E Eriksson

16 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Eriksson United States 14 504 183 96 76 65 16 651
Konstadinos Kosmatopoulos France 8 520 1.0× 94 0.5× 205 2.1× 79 1.0× 91 1.4× 13 637
Laurie May United States 5 378 0.8× 168 0.9× 264 2.8× 203 2.7× 116 1.8× 7 734
Henry C. Outzen United States 12 233 0.5× 135 0.7× 102 1.1× 30 0.4× 67 1.0× 21 470
H. Robson MacDonald Switzerland 16 941 1.9× 225 1.2× 150 1.6× 120 1.6× 54 0.8× 30 1.1k
E Braakman Netherlands 7 456 0.9× 144 0.8× 115 1.2× 63 0.8× 53 0.8× 15 597
Lars Franksson Sweden 18 975 1.9× 205 1.1× 124 1.3× 39 0.5× 75 1.2× 23 1.1k
D B Murphy United States 11 510 1.0× 86 0.5× 126 1.3× 174 2.3× 48 0.7× 17 642
E M Shevach United States 13 656 1.3× 88 0.5× 131 1.4× 113 1.5× 34 0.5× 20 809
Roanna Ueda United States 7 382 0.8× 88 0.5× 188 2.0× 54 0.7× 114 1.8× 9 615
C. Bourali France 7 284 0.6× 205 1.1× 88 0.9× 35 0.5× 75 1.2× 11 463

Countries citing papers authored by E Eriksson

Since Specialization
Citations

This map shows the geographic impact of E Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Eriksson more than expected).

Fields of papers citing papers by E Eriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Eriksson. The network helps show where E Eriksson may publish in the future.

Co-authorship network of co-authors of E Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of E Eriksson. A scholar is included among the top collaborators of E Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Eriksson. E Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ullenhag, Gustav, Jan‐Erik Frödin, Mahmood Jeddi‐Tehrani, et al.. (2004). Long lasting CEA specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and GM-CSF. The antibody response correlated significantly to survival. Journal of Clinical Oncology. 22(14_suppl). 2516–2516. 1 indexed citations
2.
Dhar, Sumeer, Joachim Gullbo, K Csóka, et al.. (2000). Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients. European Journal of Cancer. 36(6). 803–809. 14 indexed citations
3.
Imboden, John B., et al.. (1989). Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokine-activated killer cells.. The Journal of Immunology. 143(9). 3100–3103. 23 indexed citations
4.
Goetzl, Edward J., Jeffrey W. Sherman, William D. Ratnoff, et al.. (1988). Receptor‐specific Mechanisms for the Responses of Human Leukocytes to Leukotrienesa. Annals of the New York Academy of Sciences. 524(1). 345–355. 14 indexed citations
5.
6.
Seaman, William E., Marvin H. Sleisenger, E Eriksson, & G C Koo. (1987). Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.. The Journal of Immunology. 138(12). 4539–4544. 154 indexed citations
7.
Heyworth, Martin F., et al.. (1986). Clearance of Giardia muris infection in mice deficient in natural killer cells. Infection and Immunity. 54(3). 903–904. 13 indexed citations
8.
Woodcock, Janet, David Wofsy, E Eriksson, Janet H. Scott, & William E. Seaman. (1986). REJECTION OF SKIN GRAFTS AND GENERATION OF CYTOTOXIC T CELLS BY MICE DEPLETED OF L3T4+ CELLS. Transplantation. 42(6). 636–641. 16 indexed citations
9.
10.
11.
Grönberg, Alvar, et al.. (1983). Gamma‐interferon (IFN‐γ) produced during effector and target interactions renders target cells less susceptible to NK‐cell‐mediated lysis. International Journal of Cancer. 32(5). 609–616. 28 indexed citations
12.
13.
Grönberg, Alvar, Rolf Kiessling, E Eriksson, & Magnus Hansson. (1981). Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.. The Journal of Immunology. 127(5). 1734–1739. 23 indexed citations
14.
Kiessling, Rolf, et al.. (1980). A comparative analysis of the cell surface properties of activated vs endogenous mouse natural killer cells.. The Journal of Immunology. 125(4). 1551–1557. 36 indexed citations
15.
Iwarson, Sten, J Ahlmén, E Eriksson, et al.. (1977). Hepatitis B Immune Globulin in Prevention of Hepatitis B among Hospital Staff Members. The Journal of Infectious Diseases. 135(3). 473–477. 24 indexed citations
16.
Iwarson, Sten, H. Kjellman, J Ahlmén, et al.. (1975). Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff. The American Journal of the Medical Sciences. 270(2). 385–390. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstadinos Kosmatopoulos Breakdown of academic impact, for papers by Laurie May Breakdown of academic impact, for papers by Henry C. Outzen Breakdown of academic impact, for papers by H. Robson MacDonald Breakdown of academic impact, for papers by E Braakman Breakdown of academic impact, for papers by Lars Franksson Breakdown of academic impact, for papers by D B Murphy Breakdown of academic impact, for papers by E M Shevach Breakdown of academic impact, for papers by Roanna Ueda Breakdown of academic impact, for papers by C. Bourali
Rankless by CCL
2026